FRACTYL HEALTH/$GUTS
1D1W1MYTD1Y5YMAX
About FRACTYL HEALTH
Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.
- Ticker
- $GUTS
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 100
- Headquarters
- Burlington, United States
- Website
- fractyl.com
FRACTYL HEALTH Metrics
BasicAdvanced
$118M
-
-$0.81
2.32
-
Price and volume
Market cap
$118M
Beta
2.32
52-week high
$2.45
52-week low
$0.38
Average daily volume
1.4M
Financial strength
Current ratio
3.152
Quick ratio
2.996
Long term debt to equity
-3,336.697
Total debt to equity
-3,647.808
Profitability
EBITDA (TTM)
-84.766
Management effectiveness
Return on assets (TTM)
-74.57%
Return on equity (TTM)
1,063.04%
Valuation
Price to book
-70.69
Price to tangible book (TTM)
-70.69
Price to free cash flow (TTM)
-1.175
Free cash flow yield (TTM)
-85.08%
Free cash flow per share (TTM)
-0.631
Growth
Earnings per share change (TTM)
-60.59%
3-year earnings per share growth (CAGR)
-72.64%
What the Analysts think about FRACTYL HEALTH
Analyst ratings (Buy, Hold, Sell) for FRACTYL HEALTH stock.
FRACTYL HEALTH Financial Performance
Revenues and expenses
FRACTYL HEALTH Earnings Performance
Company profitability
FRACTYL HEALTH News
AllArticlesVideos
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 20, 2026 in Fractyl Health, Inc. Lawsuit - GUTS
Business Wire2 days ago
GUTS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Fractyl Investors of Securities Class Action Lawsuit Deadline on October 20, 2026
Newsfile Corp2 days ago
Law Offices of Frank R. Cruz Encourages Fractyl Health, Inc. (GUTS) Shareholders to Inquire About Securities Fraud Class Action
Business Wire3 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.